All articles by Linda Stewart – Page 9
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsScientist who deployed glowing stars to detect disease named fellow of the Royal Society of Chemistry
The man who turned the science of glow-in-the-dark stars into ways to detect disease, Professor Richard Willson, has been elected as a fellow of the Royal Society of Chemistry.
-
NewsWhite blood cells use brute force to dislodge bacteria
A $2.3 million grant from the National Institutes of Health (NIH).will support research into blood platelets and macrophages; how integrin tension influences cell function; and how this force affects platelet behavior.
-
NewsAMI member Christopher Stewart named as laureate in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Professor Christopher Stewart of Newcastle University has been named as one of three 2025 laureates in the eighth Blavatnik Awards for Young Scientists in the UK.
-
NewsHidden dangers and myths: What you need to know about HPV and cancer
While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that ...
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsCentauri Therapeutics selects first clinical candidate for immunotherapeutic treatment of Gram-negative bacterial infections
Centauri Therapeutics Limited has announced the selection of its first clinical candidate in the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial infections in the lung.
-
NewsStudy uncovers the core principles of low-resistance antibiotics
Researchers have demonstrated that a dual-target approach, combining membrane disruption with an additional critical cellular pathway, significantly prevents the development of resistance in bacteria.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
NewsCan Rhizobium + low P increase the yield of common bean in Ethiopia?
A study found that bean inoculation with Rhizobium alone or in combination with P application, can increase grain yield of two common bean cultivars in Ethiopia.
-
NewsProactively exposing ecosystems to mild environmental stressors appears to offer protection
Mild, proactive exposure to environmental stress can help biological communities resist severe disturbances and maintain genetic diversity, a recent study has found.
-
NewsThe math behind social distancing: the rules that influence epidemic behavior
Researchers have worked out how to understand social distancing behavior. The team identified simple rules that govern how individuals adapt their behavior during an epidemic in order to balance the costs of infection and social distancing.
-
NewsMotion capture: In a world first, motility apparatus of Mycoplasma mobile clarified
Mycoplasmas, including bacteria that cause pneumonia in humans, are generally nonmotile, but Mycoplasma mobile, as the species name suggests, has been found in the gills of fish and seems to move by gliding along surfaces. The molecular structure that allows it to do so has for the first time been ...
-
NewsNew COVID-flu vaccine platform could provide broad, lasting protection
Researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.
-
NewsScientists probe how phytosiderophore regulates the rhizosphere dialogue between plants and microorganisms
DMA is a common phytosiderophore with the ability to activate the insoluble iron in soil, but has major limitations. A synthesized DMA analog, PDMA, is used to explore the response of rhizosphere microbes under the influence of phytosiderophores.
-
NewsRecommendations announced for influenza vaccine composition for the 2025-2026 northern hemisphere influenza season
The World Health Organization (WHO) has announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere.
-
NewsResearchers develop enhanced method for wastewater surveillance of antibiotic resistance
To better monitor the emergence and spread of antibiotic resistance, researchers have developed a CRISPR-enriched metagenomics method for the enhanced surveillance of antibiotic resistance genes, ARGs, in wastewater.
-
NewsResearchers reveal key mechanism behind bacterial cancer therapy
A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
-
NewsSynthetic microbiome therapy suppresses bacterial infection without antibiotics
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans. Clostridioides difficile is a bacterium that can cause severe diarrhea, abdominal pain and colon inflammation.
-
NewsIsolated population of chlamydia-free koalas even more vulnerable to the disease
Koalas in south-western Sydney are among the very few in New South Wales (NSW) still free of chlamydia, yet a new study shows they are less likely to adapt to the disease should it arrive on their doorstep.